Skip to content

Role of Pathya Ahara (Wholesome Diet) in AMAVATA(Rheumatoid Arthritis).

A Randomised Open Label Controlled Clinical Study to Evaluate the Efficacy of Pathya Ahara along with Rasonadi Kwatha and Rasonadi Kwatha alone in the management of Amavata with special reference to Rheumatoid Arthritis - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074459
Enrollment
30
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Sponsors

Jammu Institute of Ayurveda and Research Jammu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having Cardinal Signs and Symptoms of Amavata will be considered for present study 2. Patients of both the gender between the age group of 16-60 years presenting Clinical 3. Patients who follow the American College of Rheumatology (ACR) 2010 Criteria.

Exclusion criteria

Exclusion criteria: Patients aged below 16 years and above 60 years. 2. Gout, Osteoarthritis, Ankylosing Spondylitis, Osteomyelitis 3. Pregnant and lactating women. 4. Arthritis with malignancy. 5. Psoriatic Arthritis, Rheumatic fever, Asymmetrical Arthritis. 6. Ulnar deviation, Swan neck deformity of wrist and elbow. 7. Patient suffering from other systemic complicated diseases like Diabetes Mellitus, Pulmonary Tuberculosis, Hyperthyroidism, Hypothyroidism etc.

Design outcomes

Primary

MeasureTime frame
Subjective Parameters: The Signs and Symptoms of Amavata as per Ayurvedic classics: ? Sandhistabdhata (Morning stiffness) ? Sandhishoola (Pain) ? Sandhishotha (Swelling) ? Apaka (Indigestion) Objective Parameters: ? ESR ? R.A Factor ? CRP Timepoint: Baseline

Secondary

MeasureTime frame
1.Range of movement of affected joints. 2.Number of joints involvedTimepoint: Baseline,15th day ,30th day , 45th day

Countries

India

Contacts

Public ContactDr Poonam Gupta

Jammu Institute of Ayurveda and Research Jammu

drpoonamgupta03@gmail.com9149696904

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026